We report a case of autoimnmune haemolytic anaemia complicated by ineffective erythropoiesis associated with florid sideroblastic change in the bone marrow.
Introduction
A poor reticulocyte response to haemolysis can be a manifestation of secondary marrow aplasia, but a hypercellular erythroid marrow response with reticulocytopenia is also recognised. We report a case where autoimmune thrombocytopenia occurred 2 years before a haemolytic crisis. The latter was complicated by reticulocytopenia and an abundance of ring sideroblasts in the bone marrow. The changes reversed with pyridoxine and prednisolone therapy.
Case report
A 24-year-old man presented in February 1980 with autoimmune thrombocytopenic purpura. The marrow showed abundant megakaryocytes but was otherwise normal. Complement fixing antibody to platelets was demonstrated. He made a prompt and complete recovery with corticosteroids.
He presented again in September 1982 with a 3-day history of jaundice and faintness. He had been on no medication. He was markedly pale and jaundiced but no splenomegaly or other abnormality was found. His haemoglobin was 3-8 g/dl with 78 x 109/l (7%) reticulocytes. His white count and platelets were normal and autoimmune proffle negative. The serum bilirubin was very raised (165 nmol/l, all unconjugated) and the Coombs' test strongly positive. Haptoglobins were absent and red cell folate was normal. He was cautiously transfused and commenced on prednisolone, 60 mg, and folic acid, 15 mg daily. After 3 days and four units of packed red cells his haemoglobin was only 3-6 g/dl and the reticulocyte count very low at 5 x 109/1 (1%).
Bone marrow aspirate was cellular with active erythropoiesis, increased iron stores and plentiful ring sideroblasts. He was given a total of 10 further units of packed red cells, prednisolone was increased to 100 mg daily and pyridoxine prescribed. He then developed a prompt reticulocyte response and made a full recovery (Fig. 1) . He was well 10 weeks later with a haemoglobin of 12-2 g/dl, and a normal serum bilirubin. Sideroblasts were no longer present in the bone marrow.
Discussion
This patient displays Evan's syndrome, in which autoimmune haemolysis and thrombocytopenia occur either simultaneously or in sequence. A poor reticulocyte response to haemolysis is usually due to marrow aplasia or folic acid deficiency. In addition Conley et al. (1982) described five cases where reticulocytopenia occurred in association with an erythroid marrow. One of their patients was investigated with ferrokinetic studies and the characteristics of the autoantibody determined. They concluded that the antibody prevented the release of reticulocytes into the blood.
We do not consider that the marrow changes in our patient represent recovery from an aplastic arrest before presentation. While we cannot exclude this possibility, it is unlikely because the reticulocyte count was lowest on the day when the marrow aspirate showed erythroid hyperplasia and remained inappropriately low for the degree of haemolysis for several days subsequently.
We have found two reports on sideroblastosis in autoimmune haemolysis. McFadzean and Davis (1947) described seven cases where iron staining granules and occasional ring forms were seen in the marrow; their presence correlated with the degree of haemolysis and yet the reticulocyte response remained good. Folic acid assays were not done. Celada, Farquet and Muller (1977) reported chronic haemolysis, reticulocytopenia and a sideroblastic marrow in an elderly patient on immunosuppressives. Our case is noteworthy because previous and follow-up marrow aspirates showed no abnormality of the red cell precursors. It is likely that the marrow changes significantly increased the transfusion requirement in this haemolytic crisis. It also raises the question as to whether pyridoxine deficiency leading to sideroblastic change can occur in haemolytic crises. 
